Table 1.
The range of expression for seven genes and a median value used to stratify patient samples from public data sets into the groups of high expression and low expression.
| GATA3 | NTN4 | SLC7A8 | MLPH | ENPP1 | LAMB2 | PLAT | |||
|---|---|---|---|---|---|---|---|---|---|
| Cohort I: 195 estrogen receptor positive (ER +) patient samples | |||||||||
| mRNA expression range | 1.7 to −4.1 | 2.7 to −3.9 | 1.5 to −4.0 | 2.2 to −2.1 | 2.5 to −2.5 | 1.1 to −1.2 | 2.8 to −3.2 | ||
| Cut-off value | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Number of high expression samples | 95 | 96 | 97 | 91 | 97 | 96 | 95 | ||
| Number of low expression samples | 100 | 99 | 98 | 104 | 98 | 99 | 100 | ||
| Cohort II: 109 ER (+) and node (+) patient samples | |||||||||
| mRNA expression range | 1.4 to −3.0 | 1.0 to −3.3 | 2.3 to −1.4 | 2.8 to −2.7 | 1.6 to −2.0 | 1.2 to −1.1 | 2.8 to −3.2 | ||
| Cut-off value | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Number of high expression samples | 22 | 22 | 22 | 22 | 22 | 22 | 22 | ||
| Number of low expression samples | 87 | 87 | 87 | 87 | 87 | 87 | 87 | ||
| Cohort III: 67 ER (+) samples with 3-gene combined expression | Cohort IV: 43 ER (+) Node (+) samples with 3-gene combined expression | ||||||||
| GATA3/NTN4/MLPH | GATA3/SLC7A8/MLPH | ||||||||
| Cut-off value | 0.0 | 0.0 | |||||||
| Number of high expression samples | 30 | 20 | |||||||
| Number of low expression samples | 37 | 23 | |||||||